使用FlexCrown牵开器的微创二尖瓣手术:一种安全有效的新型自扩展左心房暴露装置。

IF 1.6 Q2 SURGERY
Sara Volpi, Joy Eldin, Bonnie Kyle, Kostas Savvatis, Oliver Guttmann, Ragi Nagib, Samir Ahad, Ulrich Franke, Magdalena Rufa, Dincer Aktuerk
{"title":"使用FlexCrown牵开器的微创二尖瓣手术:一种安全有效的新型自扩展左心房暴露装置。","authors":"Sara Volpi, Joy Eldin, Bonnie Kyle, Kostas Savvatis, Oliver Guttmann, Ragi Nagib, Samir Ahad, Ulrich Franke, Magdalena Rufa, Dincer Aktuerk","doi":"10.1177/15569845251348195","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Minimally invasive mitral valve surgery (MIMVS) is being increasingly adopted worldwide. Pivotal to the safe conduct of the procedure is optimal visualization to allow detailed valve analysis and assessment of reparability. Positioning of conventional transthoracic left atrial retractors used during MIMVS may be time-consuming and can result in a limited view or thoracic bleeding. The aim of this study was to evaluate the safety and efficacy of the FlexCrown™ retractor by Geister (Tuttlingen, Germany), an innovative self-expandable left atrial retractor, during MIMVS.</p><p><strong>Methods: </strong>A retrospective analysis was performed of 245 patients at 2 mitral specialist centers from January 2017 to July 2022. All patients underwent MIMVS via a right minianterolateral thoracotomy using the FlexCrown retractor.</p><p><strong>Results: </strong>There were 129 female (53%) and 116 male (47%) patients with a mean age of 67 ± 10 years. The etiology of the mitral valve pathology was stenosis in 11% of patients (<i>n</i> = 27), regurgitation in 80% (<i>n</i> = 196), and mixed in 9% (<i>n</i> = 22). The device was used for both mitral valve repair (<i>n</i> = 125) and replacement (<i>n</i> = 120). There were no cases of tissue damage, dislodgement, or migration of the FlexCrown retractor. The postoperative transthoracic echocardiogram showed no or trivial mitral regurgitation in 90% of patients (<i>n</i> = 220).</p><p><strong>Conclusions: </strong>The FlexCrown self-expandable left atrial retractor by Geister allows excellent and safe exposure of the mitral valve with fast deployment and removal during MIMVS. The use of this innovative retractor may represent a helpful alternative to conventional left atrial retractors.</p>","PeriodicalId":13574,"journal":{"name":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","volume":" ","pages":"15569845251348195"},"PeriodicalIF":1.6000,"publicationDate":"2025-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Minimally Invasive Mitral Valve Surgery Using the FlexCrown Retractor: A Safe and Effective New Self-Expandable Left Atrial Exposure Device.\",\"authors\":\"Sara Volpi, Joy Eldin, Bonnie Kyle, Kostas Savvatis, Oliver Guttmann, Ragi Nagib, Samir Ahad, Ulrich Franke, Magdalena Rufa, Dincer Aktuerk\",\"doi\":\"10.1177/15569845251348195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Minimally invasive mitral valve surgery (MIMVS) is being increasingly adopted worldwide. Pivotal to the safe conduct of the procedure is optimal visualization to allow detailed valve analysis and assessment of reparability. Positioning of conventional transthoracic left atrial retractors used during MIMVS may be time-consuming and can result in a limited view or thoracic bleeding. The aim of this study was to evaluate the safety and efficacy of the FlexCrown™ retractor by Geister (Tuttlingen, Germany), an innovative self-expandable left atrial retractor, during MIMVS.</p><p><strong>Methods: </strong>A retrospective analysis was performed of 245 patients at 2 mitral specialist centers from January 2017 to July 2022. All patients underwent MIMVS via a right minianterolateral thoracotomy using the FlexCrown retractor.</p><p><strong>Results: </strong>There were 129 female (53%) and 116 male (47%) patients with a mean age of 67 ± 10 years. The etiology of the mitral valve pathology was stenosis in 11% of patients (<i>n</i> = 27), regurgitation in 80% (<i>n</i> = 196), and mixed in 9% (<i>n</i> = 22). The device was used for both mitral valve repair (<i>n</i> = 125) and replacement (<i>n</i> = 120). There were no cases of tissue damage, dislodgement, or migration of the FlexCrown retractor. The postoperative transthoracic echocardiogram showed no or trivial mitral regurgitation in 90% of patients (<i>n</i> = 220).</p><p><strong>Conclusions: </strong>The FlexCrown self-expandable left atrial retractor by Geister allows excellent and safe exposure of the mitral valve with fast deployment and removal during MIMVS. The use of this innovative retractor may represent a helpful alternative to conventional left atrial retractors.</p>\",\"PeriodicalId\":13574,\"journal\":{\"name\":\"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery\",\"volume\":\" \",\"pages\":\"15569845251348195\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/15569845251348195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15569845251348195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

目的:微创二尖瓣手术(MIMVS)在世界范围内的应用越来越广泛。关键的过程安全进行是最佳的可视化,以允许详细的阀门分析和可修复性评估。在MIMVS中使用传统经胸左心房牵开器定位可能耗时,并可能导致视野受限或胸部出血。本研究的目的是评估Geister (Tuttlingen, Germany)的FlexCrown™自扩式左心房牵开器在MIMVS期间的安全性和有效性。方法:回顾性分析2017年1月至2022年7月在2个二尖瓣专科中心就诊的245例患者。所有患者均使用FlexCrown牵开器通过右小前外侧开胸行MIMVS。结果:女性129例(53%),男性116例(47%),平均年龄67±10岁。二尖瓣病变的病因为狭窄(27例)占11%,反流(196例)占80%,混合性(22例)占9%。该装置用于二尖瓣修复(n = 125)和置换术(n = 120)。没有组织损伤、移位或FlexCrown牵开器移位的病例。术后经胸超声心动图显示90%的患者无二尖瓣反流或轻微二尖瓣反流(n = 220)。结论:Geister公司的FlexCrown自膨胀左心房牵开器可以在MIMVS中快速部署和移除二尖瓣,从而实现出色和安全的暴露。使用这种创新的牵开器可能是传统左心房牵开器的一个有用的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Minimally Invasive Mitral Valve Surgery Using the FlexCrown Retractor: A Safe and Effective New Self-Expandable Left Atrial Exposure Device.

Objective: Minimally invasive mitral valve surgery (MIMVS) is being increasingly adopted worldwide. Pivotal to the safe conduct of the procedure is optimal visualization to allow detailed valve analysis and assessment of reparability. Positioning of conventional transthoracic left atrial retractors used during MIMVS may be time-consuming and can result in a limited view or thoracic bleeding. The aim of this study was to evaluate the safety and efficacy of the FlexCrown™ retractor by Geister (Tuttlingen, Germany), an innovative self-expandable left atrial retractor, during MIMVS.

Methods: A retrospective analysis was performed of 245 patients at 2 mitral specialist centers from January 2017 to July 2022. All patients underwent MIMVS via a right minianterolateral thoracotomy using the FlexCrown retractor.

Results: There were 129 female (53%) and 116 male (47%) patients with a mean age of 67 ± 10 years. The etiology of the mitral valve pathology was stenosis in 11% of patients (n = 27), regurgitation in 80% (n = 196), and mixed in 9% (n = 22). The device was used for both mitral valve repair (n = 125) and replacement (n = 120). There were no cases of tissue damage, dislodgement, or migration of the FlexCrown retractor. The postoperative transthoracic echocardiogram showed no or trivial mitral regurgitation in 90% of patients (n = 220).

Conclusions: The FlexCrown self-expandable left atrial retractor by Geister allows excellent and safe exposure of the mitral valve with fast deployment and removal during MIMVS. The use of this innovative retractor may represent a helpful alternative to conventional left atrial retractors.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.00
自引率
6.70%
发文量
80
期刊介绍: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery is the first journal whose main mission is to disseminate information specifically about advances in technology and techniques that lead to less invasive treatment of cardiothoracic and vascular disease. It delivers cutting edge original research, reviews, essays, case reports, and editorials from the pioneers and experts in the field of minimally invasive cardiothoracic and vascular disease, including biomedical engineers. Also included are papers presented at the annual ISMICS meeting. Official Journal of the International Society for Minimally Invasive Cardiothoracic Surgery
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信